Disclosure of human immunodeficiency virus (HIV) status to sexual partners in the context of prevention of mother-to-child transmission (PMTCT) may contribute to improved PMTCT outcomes. A team of researchers, including Ms. Anna Helova, doctoral candidate, and Dr. Janet Turan, professor, both from University of Alabama at Birmingham School of Public Health, administered a questionnaire to 200 women with HIV enrolled in a PMTCT study during pregnancy at 12 months after birth in Western Kenya between May-September 2017.
Descriptive analysis of disclosure patterns and multivariate analysis of factors associated with male partner reactions is presented. The majority of women reported disclosure occurred within one year of their diagnosis, with occurring within one week. The most common forms of disclosure were: self-disclosure, during couple’s HIV testing and counseling (CHTC), or at an antenatal care visit. Most women reported that male partner reactions to their HIV status disclosure were positive. Those with negative reactions reported their partners were confused, annoyed, or threatened to leave, however there were no reports of intimate partner violence (IPV) or break ups. Disclosure via CHTC was associated with a positive male partner reaction compared to self-disclosure.
Those in concordant HIV status partnerships were more likely to have a positive reaction. Most postpartum women with HIV in this cohort had disclosed to their male partners early after diagnosis and experienced a positive reaction. However, a minority had still not disclosed by 12 months after the birth and some experienced negative reactions to disclosure. The form of status disclosure and impact of intimate partner violence should be given greater attention within the context of PMTCT.Friday Letter Submission, Publish on September 13